Capital Increase / Dilution2026-07-28

Amicogen: Paid-in Capital Increase Amendment

AMI

아미코젠

092040

-0.50

Signal Score

50CNeutral
Score50 / 100

Historical Avg Return (5d)

+0.00%

Data Coverage

100%n=2632

Risk-adjusted indicator based on 2632 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEGATIVE

Key Numbers

  • • Event Type: Paid-in Capital Increase

AI Analysis Summary

Amicogen, Inc. has filed an amendment to its Material Fact Report regarding a decision on a paid-in capital increase. This type of event typically leads to share dilution, potentially negatively impacting existing shareholder value. The specific terms, such as issuance price, number of new shares, and funding size, are not available in the provided content, but a capital increase generally signals a need for funds, which could be for operational expansion or debt repayment. Without further details, the immediate impact is perceived as negative due to potential dilution.

How This Event Is Evaluated

Capital Raise Evaluation

Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.

AI is used to interpret disclosures and extract structured data.

Signal scores are generated using event-specific methodologies and quantitative models.

  • Potential dilution rate
  • Issuance or conversion price
  • Funding purpose
  • Shareholder value impact
Read our full scoring methodology →

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.